EVENTS CALENDAR
-
15-May-2012 to 17-May-2012 Agritech Israel 2012 -
21-May-2012 to 23-May-2012 ILSI-BioMed 2012 Conference - 11th National Life Science & Technology Week -
23-May-2012 to 24-May-2012 Electronic DAYS 2012
EUREKA NEWS
Eurostars project LIPODEL will develop an innovative drug delivery technique
date of publication > 15-September-2011The LIPODEL project brings together SMEs and institutional research organisations from Switzerland and Denmark under the lead of Telormedix, a clinical stage biopharmaceutical company based in Bioggio, Switzerland.
The project will receive a total of 729,500 euros funding under the Eurostars Programme, a European funding and support programme specifically dedicated to stimulating international collaborative research and innovation projects led by research-intensive SMEs and managed by EUREKA.
The aim of the project is to develop Liposomes, artificial structures with an important medical potential in drug delivery, immunotherapy and vaccine development.
Dr Alcide Barberis, Head of Research and Collaborations at Telormedix, has been appointed as the project’s scientific coordinator. “We are delighted to have received funding from the Eurostars Programme to coordinate the LIPODEL project,” he said. “We intend for this to be the beginning of a rewarding collaboration with Minervax, the Technical University of Denmark and the research institute Bioneer.” Barberis looks forward to working with the partners to improve immunotherapy and develop effective vaccine candidates.
Dr Johanna Holldack, CEO at Telormedix, added: “These Eurostars awards are much sought after and we consider it prestigious to be awarded one for our novel and promising adjuvant programme.”